Skip to navigation Skip to content

MS Phenotypes - Implications for Practice Webinar

Share

Details

Online

This presentation explores the 2012 phenotype definitions and modifiers and discuss the practice implications of the new FDA labeling for MS drugs approved for relapsing forms of MS. View the paper, Defining the Clinical Course of Multiple Sclerosis: The 2013 Revisions and the 2020 clarification.

Register now.

Share


© 2020 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.